Highlights: 67 percent reported weight or appetite reduction with semaglutide 80 percent experienced side effect
Vous n'êtes pas connecté
Maroc - DRUGS.COM - Pharma Industry News - 20/Feb 16:30
FRIDAY, Feb. 20, 2026 -- Satisfaction with semaglutide (Ozempic) is mainly driven by effective weight loss despite gastrointestinal side effects, according to a study published in the February issue of the Journal of Medical Internet...
Highlights: 67 percent reported weight or appetite reduction with semaglutide 80 percent experienced side effect
MONDAY, Feb. 23, 2026 — Side effects like nausea or vomiting are common among folks taking Ozempic/Wegovy, but they’ll grin and bear it if they...
MONDAY, Feb. 23, 2026 — Side effects like nausea or vomiting are common among folks taking Ozempic/Wegovy, but they’ll grin and bear it if they...
WEDNESDAY, Feb. 18, 2026 -- The risk for nonscarring hair loss (NSHL) is increased in association with glucagon-like peptide-1 receptor agonist (GLP-1...
WEDNESDAY, Feb. 18, 2026 -- The risk for nonscarring hair loss (NSHL) is increased in association with glucagon-like peptide-1 receptor agonist (GLP-1...
TUESDAY, Feb. 24, 2026 -- Musicians face substantially higher rates of auditory symptoms than nonmusicians, according to a study published in the...
FRIDAY, Feb. 27, 2026 -- Adult patients with cancer who experience a new-onset mental health disorder (MHD) have an increased risk for death,...
TUESDAY, March 3, 2026 -- By 2025, donation after circulatory death (DCD) donors comprised about half of deceased organ donors, according to a study...
TUESDAY, March 3, 2026 -- By 2025, donation after circulatory death (DCD) donors comprised about half of deceased organ donors, according to a study...
WEDNESDAY, Feb. 18, 2026 -- Parents of children with medical complexity (CMC) report major challenges with at-home medical devices, according to a...